Acute kidney injury (AKI) may occur in 4-23% of patients with COVID-19. Those who require renal replacement therapy have mainly been treated with extracorporeal dialysis. However, peritoneal dialysis (PD) may also be considered as a valuable treatment option in such cases when there is a capacity limit or availability constraint of equipment and supplies for extracorporeal dialysis techniques. Automated PD is the preferred option, but if not available, continuous ambulatory PD could also be used. The initial prescription should be 10 to 12 exchanges per day, tapered to 4 to 5 exchanges after 3 to 4 days, depending on the clinical evolution.